Get the Stockscreener App
2.79
17.72%
0.42
After Hours:
2.88
0.09
+3.23%
InspireMD Inc. stock is traded at $2.79, with a volume of 888.35K.
It is up +17.72% in the last 24 hours and up +22.91% over the past month.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See More
Previous Close:
$2.37
Open:
$2.43
24h Volume:
888.35K
Relative Volume:
5.66
Market Cap:
$85.47M
Revenue:
$6.21M
Net Income/Loss:
$-19.92M
P/E Ratio:
-2.6571
EPS:
-1.05
Net Cash Flow:
$-16.76M
1W Performance:
+14.34%
1M Performance:
+22.91%
6M Performance:
+8.14%
1Y Performance:
-3.12%
1-Day Range:
$2.43
$2.9199
1-Week Range:
$2.37
$2.9199
52-Week Range:
$1.99
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Name
InspireMD Inc.
Sector
Industry
Phone
972 3 6917691
Address
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.79 | 72.61M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-16 | Initiated | Rodman & Renshaw | Buy |
| Mar-13-15 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-26-13 | Initiated | Oppenheimer | Outperform |
InspireMD Inc. Stock (NSPR) Latest News
What data driven models say about InspireMD Inc.’s futureInstitutional Holding Behavior Pattern Analysis - Newser
What is InspireMD Inc. company’s growth strategyPost Market Opportunities With High Returns - jammulinksnews.com
How many analysts rate InspireMD Inc. as a “Buy”Earnings Report Alerts To Watch Now - jammulinksnews.com
InspireMD Skyrocketed 18.25%—Could This Be the Start of a Breakout? - AInvest
InspireMD's Strategic Leadership Evolution: How Raymond W. Cohen's Appointment Strengthens Governance and Signals Long-Term Value Creation - AInvest
InspireMD Raises $40.1M in Private Placement Offering - TipRanks
InspireMD appoints medtech veteran Raymond Cohen to board - Investing.com Australia
InspireMD Announces Combined Financings of $58 Million - The Manila Times
InspireMD, Inc. Appoints Raymond W. Cohen to Board of Directors - Quiver Quantitative
InspireMD raises $58 million to fund US launch of carotid stent - Investing.com India
InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors - GlobeNewswire
InspireMD Strengthens Board with MedTech Star Who Led $3.7B Axonics Sale to Boston Scientific - Stock Titan
Using data tools to time your InspireMD Inc. exitFree Stock Selection With High Accuracy - Newser
What machine learning models say about InspireMD Inc.Free Reliable Alerts for Daily Stock Movers - Newser
What’s the recovery path for long term holders of InspireMD Inc.Swing Trade Entry and Exit Point Analysis - Newser
Is InspireMD Inc. Stock a Smart Buy in 2025 Investment Analysis InsideBreakout Confirmation With Entry Tracker Enabled - metal.it
Why InspireMD Inc. stock attracts strong analyst attentionMomentum-Based Prediction for Quick Returns - Newser
Is a relief rally coming for InspireMD Inc. holdersTrade Setups With Clear Risk Limits Highlighted - metal.it
Is InspireMD Inc. still worth holding after the dipBuy Signal Forecast With Short-Term Data - Newser
Chart based exit strategy for InspireMD Inc.Long-Term Safety Investment Analysis Report - Newser
Chartists See Breakout Potential in InspireMD Inc.Long Hold Safe Return Strategy Reviewed - metal.it
InspireMD Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Trade Ready Stock Watch for Short Term - Newser
Using portfolio simulators with InspireMD Inc. includedStock Forecast Tools for Retail Traders - Newser
Will a bounce in InspireMD Inc. offer an exitFree Weekly Stock Watch With Growth Focus - Newser
Using RSI to spot recovery in InspireMD Inc.Free Strong Buy With Technical Confidence - Newser
Is InspireMD Inc. stock bottoming outPredictable Income Summary for Long-Term Trades - Newser
Fibonacci Support Holding Strong in InspireMD Inc.Weekly Top Gainers Forecast Watchlist Released - metal.it
How InspireMD Inc. stock performs during market volatilityLow Drawdown Picks with Weekly Updates - Newser
What makes InspireMD Inc. stock price move sharplyEntry Optimization Guide with Volume Analysis - Newser
How does InspireMD Inc. compare to its industry peersInvest smarter with daily stock recommendations - jammulinksnews.com
When is InspireMD Inc. stock expected to show significant growthCapitalize on emerging industry trends - jammulinksnews.com
Does InspireMD Inc. stock perform well during market downturnsUnlock real-time trading signals for gains - jammulinksnews.com
How does InspireMD Inc. generate profit in a changing economyExplosive earning power - jammulinksnews.com
How volatile is InspireMD Inc. stock compared to the marketUnrivaled growth potential - jammulinksnews.com
What are InspireMD Inc. company’s key revenue driversGet real-time alerts on high-potential stocks - jammulinksnews.com
What is the dividend policy of InspireMD Inc. stockGet ahead with breakthrough trading ideas - jammulinksnews.com
Competitive Positioning of InspireMD Inc.: Is It Leading or LaggingFree Stock Market Swing Trading Strategies - Newser
New Product Launches: Will They Boost InspireMD Inc. Stock in 2025Free Professional Trading Signals - Newser
Key External Factors That Drive InspireMD Inc. Stock Price MovementsPortfolio Boosting Stock Alerts - Newser
InspireMD Inc. Company’s Quarterly Earnings Growth: What the Numbers SayBig Return Stock Tips - Newser
Buy Signal for InspireMD Inc. Stock Key Technical Indicators to Watch Free Investment Strategy With Predictable Gains - Newser
InspireMD Inc. Stock (NSPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):